Peng, Liang <br/><br/>
Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations.  [electronic resource] 

 -  Scientific reports  Aug 2014 
 - 6104 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep06104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Bronchiolo-Alveolar--drug therapy<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Female<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use<br/>Retrospective Studies